Grace Therapeutics (formerly Acasti Pharma)
Laval
About Grace Therapeutics (formerly Acasti Pharma)
Grace Therapeutics is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of innovative proprietary active pharmaceutical ingredients (API) for managing cardiometabolic disorders, from prevention to treatment, through a novel superior approach to lipid regulation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $108.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:GRCE
- Website: gracetx.com
- Phone: 609-322-1602
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/grace-therapeutics-formerly-acasti-pharma-2232536 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.